Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

Area of Science:

• Infectious Diseases
• Pulmonology
• Critical Care Medicine

Background:

• The global spread of SARS-CoV-2 has caused significant hospitalizations and deaths.
• The rapid transmission of COVID-19 has hindered clinical trials for outpatient therapies.
• Physicians need guidance on early outpatient treatment based on SARS-CoV-2 pathophysiology.

Purpose of the Study:

• To outline key pathophysiological principles for early outpatient treatment of COVID-19.
• To propose therapeutic strategies aimed at preventing hospitalization and death.

Main Methods:

• Review of SARS-CoV-2 pathophysiology in early infection.
• Identification of therapeutic approaches based on established principles.
• Discussion of strategies including reinoculation reduction, combination antiviral therapy, immunomodulation, antiplatelet/antithrombotic therapy, oxygen administration, monitoring, and telemedicine.

Main Results:

• Therapeutic approaches are proposed based on understanding the pathophysiology of early SARS-CoV-2 infection.
• Specific strategies discussed aim to mitigate disease progression in outpatient settings.

Conclusions:

• Early outpatient management of COVID-19 should be guided by pathophysiological principles.
• Multifaceted therapeutic strategies are essential for preventing severe outcomes amidst hospital resource strain.
• Further randomized trials are needed to refine these early treatment principles.